285 related articles for article (PubMed ID: 28611094)
1. Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.
Lempiäinen JK; Niskanen EA; Vuoti KM; Lampinen RE; Göös H; Varjosalo M; Palvimo JJ
Mol Cell Proteomics; 2017 Aug; 16(8):1462-1474. PubMed ID: 28611094
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
[TBL] [Abstract][Full Text] [Related]
3. Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
Smith R; Liu M; Liby T; Bayani N; Bucher E; Chiotti K; Derrick D; Chauchereau A; Heiser L; Alumkal J; Feiler H; Carroll P; Korkola JE
Sci Rep; 2020 Dec; 10(1):21750. PubMed ID: 33303959
[TBL] [Abstract][Full Text] [Related]
4. TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth.
Palit SA; Vis D; Stelloo S; Lieftink C; Prekovic S; Bekers E; Hofland I; Šuštić T; Wolters L; Beijersbergen R; Bergman AM; Győrffy B; Wessels LF; Zwart W; van der Heijden MS
Elife; 2019 Dec; 8():. PubMed ID: 31855178
[TBL] [Abstract][Full Text] [Related]
5. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma.
Mitani Y; Lin SH; Pytynia KB; Ferrarotto R; El-Naggar AK
Clin Cancer Res; 2020 Mar; 26(5):1175-1184. PubMed ID: 31772120
[TBL] [Abstract][Full Text] [Related]
7. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
8. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
10. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.
Schulz M; Eggert M; Baniahmad A; Dostert A; Heinzel T; Renkawitz R
J Biol Chem; 2002 Jul; 277(29):26238-43. PubMed ID: 12011091
[TBL] [Abstract][Full Text] [Related]
11. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells.
Sahu B; Laakso M; Pihlajamaa P; Ovaska K; Sinielnikov I; Hautaniemi S; Jänne OA
Cancer Res; 2013 Mar; 73(5):1570-80. PubMed ID: 23269278
[TBL] [Abstract][Full Text] [Related]
12. Androgens modulate glucocorticoid receptor mRNA, but not mineralocorticoid receptor mRNA levels, in the rat hippocampus.
Kerr JE; Beck SG; Handa RJ
J Neuroendocrinol; 1996 Jun; 8(6):439-47. PubMed ID: 8809674
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor.
Adelaiye-Ogala R; Gryder BE; Nguyen YTM; Alilin AN; Grayson AR; Bajwa W; Jansson KH; Beshiri ML; Agarwal S; Rodriguez-Nieves JA; Capaldo B; Kelly K; VanderWeele DJ
Mol Cancer Ther; 2020 Jul; 19(7):1436-1447. PubMed ID: 32371590
[TBL] [Abstract][Full Text] [Related]
14. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
[TBL] [Abstract][Full Text] [Related]
15. Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist.
Wu M; Xie Y; Cui X; Huang C; Zhang R; He Y; Li X; Liu M; Cen S; Zhou J
Eur J Med Chem; 2019 Mar; 166():232-242. PubMed ID: 30711833
[TBL] [Abstract][Full Text] [Related]
16. Association of glucocorticoid receptors with prostate nuclear sites for androgen receptors and with androgen response elements.
Davies P; Rushmere NK
J Mol Endocrinol; 1990 Oct; 5(2):117-27. PubMed ID: 2248687
[TBL] [Abstract][Full Text] [Related]
17. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.
Arora VK; Schenkein E; Murali R; Subudhi SK; Wongvipat J; Balbas MD; Shah N; Cai L; Efstathiou E; Logothetis C; Zheng D; Sawyers CL
Cell; 2013 Dec; 155(6):1309-22. PubMed ID: 24315100
[TBL] [Abstract][Full Text] [Related]
19. BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.
Manjur ABMK; Lempiäinen JK; Malinen M; Varjosalo M; Palvimo JJ; Niskanen EA
J Steroid Biochem Mol Biol; 2021 Jun; 210():105873. PubMed ID: 33722704
[TBL] [Abstract][Full Text] [Related]
20. Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer.
Helminen L; Huttunen J; Tulonen M; Aaltonen N; Niskanen EA; Palvimo JJ; Paakinaho V
Nucleic Acids Res; 2024 Jan; 52(2):625-642. PubMed ID: 38015476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
